This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for the provision of Illumina reagent chemistry kits. The contract has a ceiling value of $147,806.45 and a period of performance ending on January 31, 2025. The award does not utilize any set-aside designations. Illumina, a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, has a history of providing sequencing systems, reagents, and related products and services to support research, diagnostics, and other applications across various federal agencies, including the NIH, CDC, USDA, and VA. This specific award is likely tied to Illumina's Indefinite Delivery Contract with the Department of the Navy's Bureau of Medicine and Surgery, which provides sequencing platforms and reagents to support the Naval Medical Research Center's efforts in characterizing biological threats.
Generated 12/19/24, 9:12 AM